NASDAQ:NVCR

NovoCure - NVCR Earnings Date, Estimates & Call Transcripts

$90.90

+0.85 (+0.94%)

(As of 01/27/2023 12:00 AM ET)

Add

Compare

Today's Range: $88.72
▼
$91.69
50-Day Range: $67.94
▼
$118.81
52-Week Range: $56.39
▼
$120.03

Volume: 542,608 shs
Average Volume: 1.70 million shs
Market Capitalization: $9.54 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $110.13

Institutional Ownership

Upcoming Earnings Date: Feb. 23Confirmed
Actual EPS (Oct. 27): -$0.25 Beat By $0.05
Consensus EPS (Oct. 27): -$0.30
Last Year's Q4 EPS (10/28/2021): -$0.13

Earnings Per Share Revenue

NVCR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NVCR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

NovoCure Analyst Forecasts

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2023	1	$0.00	$0.00	$0.00
Q2 2023	2	($0.21)	$0.01	($0.10)
Q3 2023	2	($0.21)	$0.03	($0.09)
Q4 2023	2	($0.21)	$0.05	($0.08)
FY 2023	7	($0.63)	$0.09		($0.27)

NVCR Earnings Date and Information

NovoCure last posted its quarterly earnings data on October 27th, 2022. The medical equipment provider reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.05. The company earned $131 million during the quarter, compared to the consensus estimate of $134.83 million. NovoCure has generated ($0.77) earnings per share over the last year (($0.77) diluted earnings per share). Earnings for NovoCure are expected to decrease in the coming year, from ($0.85) to ($1.15) per share. NovoCure has confirmed that its next quarterly earnings report will be published on Thursday, February 23rd, 2023. NovoCure will be holding an earnings conference call on Thursday, February 23rd at 8:00 AM Eastern. Interested parties can register for or listen to the call..

NovoCure Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
2/23/2023 (Confirmed)		($0.32)
10/27/2022	Q3 2022	($0.30)	($0.25)	+$0.05	($0.25)	$134.83 million	$131.00 million
7/28/2022	Q2 2022	($0.14)	($0.23)	($0.09)	($0.23)	$135.13 million	$140.90 million
4/28/2022	Q1 2022	($0.17)	($0.04)	+$0.13	($0.04)	$134.29 million	$137.50 million
2/24/2022	Q4 2021	($0.10)	($0.25)	($0.15)	($0.25)	$134.49 million	$133.20 million
10/28/2021	9/30/2021	($0.06)	($0.13)	($0.07)	($0.13)	$141.22 million	$133.61 million
7/29/2021	6/30/2021	$0.02	($0.14)	($0.16)	($0.14)	$141.50 million	$133.52 million

4/29/2021	3/31/2021	$0.02	($0.04)	($0.06)	($0.04)	$136.54 million	$134.70 million
2/25/2021	12/31/2020	$0.13	$0.04	($0.09)	$0.04	$143.49 million	$144.00 million
10/29/2020	9/30/2020	$0.04	$0.09	+$0.05	$0.09	$120.02 million	$132.70 million
7/30/2020	6/30/2020	$0.01	$0.02	+$0.01	$0.02	$105.96 million	$115.90 million
4/30/2020	3/31/2020	$0.03	$0.04	+$0.01	$0.04	$102.10 million	$101.83 million
2/27/2020	12/31/2019	$0.02	$0.04	+$0.02	$0.04	$99.10 million	$99.23 million
10/31/2019	Q3	($0.05)	$0.02	+$0.07	$0.02	$87.12 million	$92.06 million
7/25/2019	Q2	($0.07)	($0.01)	+$0.06	($0.01)	$78.98 million	$86.70 million
5/2/2019	3/31/2019	($0.13)	($0.13)		($0.13)	$72.85 million	$73.31 million
2/28/2019	Q4 2018	($0.15)	($0.17)	($0.02)	($0.17)		$69.67 million
10/25/2018	9/30/2018	($0.15)	($0.13)	+$0.02	($0.13)	$65.61 million	$64.76 million
7/26/2018	Q2	($0.16)	($0.17)	($0.01)	($0.17)	$59.53 million	$61.50 million
4/26/2018	3/31/2018	($0.13)	($0.23)	($0.10)	($0.23)	$57.13 million	$52.13 million
2/22/2018	Before Market	($0.14)	($0.12)	+$0.02	($0.12)	$53.17 million	$53.66 million
10/26/2017	9/30/2017	($0.20)	($0.13)	+$0.07	($0.13)	$43.45 million	$50.10 million
7/27/2017	6/30/2017	($0.23)	($0.24)	($0.01)	($0.24)	$42.20 million	$38.38 million
4/27/2017	3/31/2017	($0.25)	($0.21)	+$0.04	($0.21)	$39.46 million	$34.88 million
2/23/2017	Q416	($0.39)	($0.26)	+$0.13	($0.26)	$26.95 million	$30.20 million
11/2/2016	Q3 2016	($0.42)	($0.39)	+$0.03	($0.39)	$21.65 million	$21.67 million
7/28/2016	Q216	($0.37)	($0.48)	($0.11)	($0.48)	$15.90 million	$17.90 million
5/9/2016	Q116	($0.33)	($0.42)	($0.09)	($0.42)	$23.65 million	$13.10 million
2/29/2016	Q4 2015	($0.32)	$2.54	+$2.86	$2.54	$17.85 million	$12.38 million
10/26/2015	Q315		($2.09)	($2.09)	($2.09)	$4.37 million	$8.95 million

NovoCure Earnings - Frequently Asked Questions

When is NovoCure's earnings date?: NovoCure has confirmed that its next quarterly earnings data will be published on Thursday, February 23rd, 2023. Learn more on NVCR's earnings history.
Did NovoCure beat their earnings estimates last quarter?: In the previous quarter, NovoCure (NASDAQ:NVCR) reported ($0.25) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.30) by $0.05. Learn more on analysts' earnings estimate vs. NVCR's actual earnings.

How much revenue does NovoCure generate each year?: NovoCure (NASDAQ:NVCR) has a recorded annual revenue of $535.03 million.
How much profit does NovoCure generate each year?: NovoCure (NASDAQ:NVCR) has a recorded net income of -$58.35 million. NVCR has generated -$0.77 earnings per share over the last four quarters.
What is NovoCure's EPS forecast for next year?: NovoCure's earnings are expected to decrease from ($0.85) per share to ($1.15) per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:

Earnings By Country:

Latest Articles:

Upcoming Earnings:

Amgen (1/31/2023)
Advanced Micro Devices (1/31/2023)
Mondelez International (1/31/2023)
Caterpillar (1/31/2023)
Chubb (1/31/2023)
Canadian Pacific Railway (1/31/2023)
General Motors (1/31/2023)
McDonald's (1/31/2023)
Moody's (1/31/2023)
Marathon Petroleum (1/31/2023)

This page (NASDAQ:NVCR) was last updated on 1/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

NovoCure - NVCR Earnings Date, Estimates & Call Transcripts

NVCR Earnings Estimates and Actuals by Quarter

NVCR Estimated and Actual Revenue by Quarter

NovoCure Analyst Forecasts

NVCR Earnings Date and Information

NovoCure Earnings History by Quarter

NovoCure Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info

NovoCure - NVCR Earnings Date, Estimates & Call Transcripts

Earnings Summary

NVCR Earnings Estimates and Actuals by Quarter

NVCR Estimated and Actual Revenue by Quarter

NovoCure Analyst Forecasts

NVCR Earnings Date and Information

NovoCure Earnings History by Quarter

NovoCure Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat